The FDA announced Friday that it is postponing the meeting because “new data have recently emerged.  This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines. We will provide an update on timing for the advisory committee meeting once we receive additional data on a third dose in this age group from the company’s ongoing clinical trial and have an opportunity to complete an updated evaluation.”

https://citizenfreepress.com/breaking/pfizer-withdraws-fda-application-to-vaccinate-children-under-5/